British scientists have found that for this terrible cancer, the 5-year survival rate of patients is only 6.8%
A multidisciplinary research team led by the University of Nottingham in the UK has discovered a new method that can use charged molecules to trigger cancer cell self destruction, thereby targeting and killing cancer cells in difficult to treat brain tumors. This method is expected to develop into the spray treatment used in surgery in the future. The related research was published in the 14th issue of the journal Nature Nanotechnology.
The focus of this study is on glioblastoma cells derived from patients. Glioblastoma is an elusive and terrifying brain cancer, with a 5-year survival rate of only 6.8% and an average survival time of only 8 months after diagnosis. There has been no effective treatment for a long time.
This time, the research team used biological nanoantennas to induce programmed cell death, also known as apoptosis, in cancer cells under electrical stimulation. The biological nanoantenna is wrapped in gold nanoparticles with special redox active molecules, which can specifically target glioblastoma cells, while healthy cells remain unscathed. Spraying or injecting biological nanoantennas during surgical resection of tumors provides new possibilities for precise treatment.
Researchers say this is considered the first "quantum therapy" that utilizes the potential of quantum signal transduction to combat cancer. Under the guidance of quantum biology, cancer cells succumb to the complex "electronic dance". By precisely modulating the quantum bioelectron tunneling effect, these clever nanoparticles play a symphony of electronic signals, triggering the self destructive mechanism of cancer cells.
The team has applied for a patent for this technology and is beginning to translate it into final clinical applications, but further rigorous research and validation are needed to ensure the safety and effectiveness of biological nanoantennas used by humans.
For a long time, treating glioblastoma has been a challenge faced by clinical doctors, and the prognosis of patients remains poor. This study demonstrates the potential of quantum therapy as a new technology connected to biology. The integration of quantum bioelectronics and medicine is expected to open up a new paradigm for disease treatment.